Enhancing Survival and Minimizing Toxicity: Leveraging New Research in HER2+ and HR+/HER2- Breast Cancers is a 4.50 hour internet enduring activity designed to deliver knowledge-based education regarding novel and emerging therapies as well as competency focused education to support precision medicine for breast cancer patients.

Clinical Advances in the Landscape of Renal Cell Carcinoma (RCC): Role of Immunotherapies in Treatment is a 2 hour internet enduring material designed for medical oncologists and the multidisciplinary care team with the purpose of sharing recent data on approved and emerging immunotherapies to improve treatment of renal cell carcinoma (RCC).

This educational activity is designed for medical oncologists and the multidisciplinary care team with the purpose of sharing recent data on approved and emerging immunotherapies to improve treatment of renal cell carcinoma (RCC), including combination anti-VEGF and immunotherapeutic platforms. Best practices will also be shared for detection and management of immunotherapy and immunotherapy combination related adverse events in RCC patients and strategies for management to help mitigate them. T...

This educational activity is designed for medical oncologists and the multidisciplinary care team with the purpose of sharing recent data on approved and emerging immunotherapies to improve treatment of renal cell carcinoma (RCC), including combination anti-VEGF and immunotherapeutic platforms. Best practices will also be shared for detection and management of immunotherapy and immunotherapy combination related adverse events in RCC patients and strategies for management to help mitigate them. T...

This educational activity is designed for medical oncologists and the multidisciplinary care team with the purpose of sharing recent data on approved and emerging immunotherapies to improve treatment of renal cell carcinoma (RCC), including combination anti-VEGF and immunotherapeutic platforms. Best practices will also be shared for detection and management of immunotherapy and immunotherapy combination related adverse events in RCC patients and strategies for management to help mitigate them. T...

AML Pathfinder is a 1 hour internet enduring material designed to provide practical guidance regarding incorporating new treatment options integrated with clinical information, data, and guidelines.  

This internet enduring material is intended to educate healthcare professionals how to provide tobacco/nicotine counseling to adults and adolescents. 

Sepsis and Oncology Training Module is a 1 hour internet enduring material with the goal to ensure that clinicians caring for cancer patients understand the heightened susceptibility of cancer patients to sepsis and the resulting need for consistent screening.  

Improving Outcomes in Acute Myeloid Leukemia: Personalizing Treatment with New Therapeutic Agents is a 1 hour, enduring material internet course.